News and Events

November 16, 2018

Inversago Pharma’s CEO François Ravenelle will attend Biotech Showcase to be held January 7-9, 2019 in San Francisco, CA. Come and meet with us!

July 25, 2018

Inversago Pharma receives $7 million in series A financing.

December 14, 2017

Inversago Pharma’s CEO François Ravenelle will attend Biotech Showcase, January 8-10th, 2018 in San Francisco, CA.

September 02, 2017

Inversago Pharma’s CEO François Ravenelle will attend RESI Boston event on September 26th.

April 26, 2016

Inversago Pharma announces the execution of license agreement with US NIH's CB1 inverse agonist technology.

October 28, 2015

National Institutes of Health Notice on Prospective Grant of Exclusive License.